The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
Separately, an IAF aircraft conducted a precision strike, targeting a Hamas terrorist in the al-Furqan neighborhood of Gaza City. Information ...
A driver involved in a tragic hit-and-run incident in Phuket turned himself into the police. Police confirmed that the driver will face charges for his actions following the fatal accident that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback